Source: Annual Congress 2006 - Genetics in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
D. Stav (Zerrifin, Israel). Genes expressions subtraction of non-cancerous tissue from smokers and non-smokers with adenocarcinoma of lung, may be used as markers for early detection of lung cancer in smoker. Eur Respir J 2006; 28: Suppl. 50, 4691

Member's Comments

No comment yet.

Related content which might interest you: Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Primary adenocarcinoma of the lung in smokers and never smokers Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004 Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 Comparative characteristics of lung cancer in smokers and nonsmokers Source: Eur Respir J 2001; 18: Suppl. 33, 115s Year: 2001 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 CD44v6 expression in tissue of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Small cell lung cancer in never-smokers Source: Eur Respir J 2016; 47: 947-953 Year: 2016 Panel of biomarkers designating bronchial epithelium differences in smokers and NSCLC Source: Annual Congress 2007 - Lung injury and repair: from in vitro to in vivo Year: 2007 No impact of passive smoke on the somatic profile of lung cancers in never-smokers Source: Eur Respir J 2015; 45: 1415-1425 Year: 2015 COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Lung cancer occurrence in never smokers Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Influence of smoking on gene expression in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening? Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018 Year: 2018 Characteristics of nonsmoker lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005 Angiogenetic and apoptotic process in the airways of symptomatic smokers with and without a contralateral non small cell lung cancer Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003